Home › Relapsing-Remitting Multiple Sclerosis › California
Pag-aaral pangklinika para sa Relapsing-Remitting Multiple Sclerosis sa California
6 pag-aaral para sa Relapsing-Remitting Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa California.
Opisyal na teksto ng pag-aaral (English)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Stanford Multiple Sclerosis Center, Palo Alto
Nagre-recruitPhase 3
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04047628Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0114, Loma Linda
- University of California Davis Health, Sacramento
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- University of California Irvine Center for Clinical Research, Irvine
Nagre-recruit
Edad 22 hanggang 60 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06796504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
Nagre-recruitPhase 1/2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05359653"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 31, 2025 · NCT07222618MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryoMay bayad para sa mga kalahok
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2024 · NCT05204459Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.